What if one of the most overlooked routes to EBITDA improvement is already built into the products a company sells?
In many portfolio companies, the product portfolio carries more financial leverage than it appears to at first glance. Decisions around architecture, specifications, variants, materials, positioning and development priorities can quietly shape margins, pricing power and operating complexity.
For investors, this means product should not be treated only as an R&D topic. It can be a direct value creation lever.
A product range that has evolved over years often accumulates complexity: too many variants, duplicated components, unnecessary features, fragmented platforms or engineering resources spread across projects with limited commercial impact.
Individually, these issues may seem operational. Together, they can materially affect profitability.
Where product meets the P&L
Product improvement can influence EBITDA from both directions.
On the cost side, simplifying architectures, reducing unnecessary components and applying value engineering can lower COGS and reduce manufacturing complexity. A more focused portfolio can also decrease the internal effort required across engineering, procurement, operations and supply chain.
On the revenue side, stronger differentiation and clearer positioning can improve perceived value, support pricing and create a healthier product mix. Better roadmap decisions can also concentrate resources on the products and markets with the greatest growth potential.
The key is to connect each product initiative to a measurable financial outcome.
Why these opportunities remain untapped
The obstacle is rarely a lack of capability.
Internal teams know their products extremely well. The issue is that they are usually focused on keeping the business running: engineering changes, production problems, customer requests, launches, supplier issues and ongoing development projects.
There is little time to step outside the existing system and ask more fundamental questions.
Where is complexity destroying margin?
Which products deserve investment?
What should be simplified or eliminated?
Where could differentiation support a higher price?
Which product initiatives could generate the greatest financial return?
SARDI PRO CAPITAL works alongside portfolio company teams to answer those questions and turn the findings into execution. As a Product Operating Partner, we connect product expertise with the investment objectives of growth, margin improvement and enterprise value.
The objective is not product development for its own sake.
It is to create a direct bridge between product decisions and financial performance.
Because when product strategy is connected to the P&L, product becomes more than an offering, it becomes an EBITDA lever.
